Published in J Transplant on November 19, 2012
Regulatory B cells: an exciting target for future therapeutics in transplantation. Front Immunol (2014) 0.92
Monocyte-Derived Suppressor Cells in Transplantation. Curr Transplant Rep (2015) 0.79
Peripheral regulatory cells immunophenotyping in primary Sjögren's syndrome: a cross-sectional study. Arthritis Res Ther (2013) 0.79
Regulatory B cells in infectious disease (Review). Mol Med Rep (2017) 0.75
Renal transplant recipient with advanced HIV infection: graft and peripheral cell population analysis. Clin Case Rep (2013) 0.75
IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol (2004) 10.08
The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature (2007) 7.82
T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. Immunity (2007) 6.61
Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci U S A (2002) 6.19
Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med (1999) 5.26
CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity (2010) 5.13
Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood (2004) 5.10
Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood (2010) 4.28
Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity (2004) 4.11
Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science (2002) 4.02
Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J Immunol (2005) 3.95
Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation? Immunol Today (1999) 3.74
Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest (2010) 3.59
Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. J Clin Invest (2010) 3.41
Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J Exp Med (1996) 3.36
Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells. J Immunol (2004) 2.77
IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro. Eur J Immunol (2010) 2.67
Cutting edge: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signaling. J Immunol (2005) 2.51
Human marginal zone B cells. Annu Rev Immunol (2009) 2.48
Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype. Kidney Int (2010) 2.28
Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses. J Immunol (2002) 2.14
Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy. Nat Med (2007) 2.08
Long-term allograft tolerance is characterized by the accumulation of B cells exhibiting an inhibited profile. Am J Transplant (2010) 1.88
Role of CD8+ CD25+ Foxp3+ regulatory T cells in multiple sclerosis. Ann Neurol (2010) 1.85
Somatic diversification in the absence of antigen-driven responses is the hallmark of the IgM+ IgD+ CD27+ B cell repertoire in infants. J Exp Med (2008) 1.75
Functional expression of indoleamine 2,3-dioxygenase by murine CD8 alpha(+) dendritic cells. Int Immunol (2002) 1.69
Toward the identification of a tolerogenic signature in IDO-competent dendritic cells. Blood (2005) 1.56
Regulatory role of mature B cells in a murine model of inflammatory bowel disease. Int Immunol (2000) 1.42
Regulatory T-cells: diverse phenotypes integral to immune homeostasis and suppression. Toxicol Pathol (2012) 1.42
Tryptophan catabolism and regulation of adaptive immunity. J Immunol (2003) 1.36
Expression and regulation of the orphan receptor RDC1 and its putative ligand in human dendritic and B cells. J Immunol (2006) 1.33
Cell-autonomous control of interferon type I expression by indoleamine 2,3-dioxygenase in regulatory CD19+ dendritic cells. Eur J Immunol (2007) 1.27
Synovial autoreactive T cells in rheumatoid arthritis resist IDO-mediated inhibition. J Immunol (2006) 1.19
IDO-expressing regulatory dendritic cells in cancer and chronic infection. J Mol Med (Berl) (2007) 1.18
Tryptophan catabolism generates autoimmune-preventive regulatory T cells. Transpl Immunol (2006) 1.12
Human T cells induce their own regulation through activation of B cells. J Autoimmun (2011) 1.03
Generation of T cell regulatory activity by plasmacytoid dendritic cells and tryptophan catabolism. Blood Cells Mol Dis (2007) 0.99
The FGL2-FcgammaRIIB pathway: a novel mechanism leading to immunosuppression. Eur J Immunol (2008) 0.97
IL-10 producing regulatory B cells in mice and humans: state of the art. Curr Mol Med (2012) 0.96
Increased liver-infiltrating CD8+FoxP3+ regulatory T cells are associated with tumor stage in hepatocellular carcinoma patients. Hum Immunol (2010) 0.93
Mechanisms dependent on tryptophan catabolism regulate immune responses in primary Sjögren's syndrome. Clin Exp Immunol (2005) 0.92
T regulatory cells in xenotransplantation. Xenotransplantation (2009) 0.90
Differences in CXCR4-mediated signaling in B cells. Immunobiology (2006) 0.89
Regulatory B cells: evidence, developmental origin and population diversity. Mol Immunol (2010) 0.89
A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet (2002) 4.03
A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis. J Exp Med (2005) 2.15
A functional ABCA1 gene variant is associated with low HDL-cholesterol levels and shows evidence of positive selection in Native Americans. Hum Mol Genet (2010) 1.60
Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis. PLoS One (2008) 1.45
HLA-DRB1*08 allele may help to distinguish between type 1 diabetes mellitus and type 2 diabetes mellitus in Mexican children. Pediatr Diabetes (2007) 1.43
"Natural" human leukocyte antigen antibodies found in nonalloimmunized healthy males. Transplantation (2008) 1.41
[On love (smell) and other demons: the extraordinary of immunogenetics]. Rev Invest Clin (2003) 1.39
HLA-DR antigen frequencies in Mexican patients with dengue virus infection: HLA-DR4 as a possible genetic resistance factor for dengue hemorrhagic fever. Hum Immunol (2002) 1.23
To stent or not to stent bilioenteric anastomosis after iatrogenic injury: a dilemma not answered? Arch Surg (2002) 1.17
Cellular and humoral mechanisms involved in the control of tuberculosis. Clin Dev Immunol (2012) 1.16
The role of complement regulatory proteins (CD55 and CD59) in the pathogenesis of autoimmune hemocytopenias. Autoimmun Rev (2006) 1.12
A major susceptibility locus for systemic lupus erythemathosus maps to chromosome 1q31. Am J Hum Genet (2002) 1.10
Genetic admixture and diversity estimations in the Mexican Mestizo population from Mexico City using 15 STR polymorphic markers. Forensic Sci Int Genet (2007) 1.09
Genetic association of IRF5 with SLE in Mexicans: higher frequency of the risk haplotype and its homozygozity than Europeans. Hum Genet (2007) 1.04
HLA class I and II polymorphisms in Mexican Mestizo patients with dengue fever. Acta Trop (2009) 1.01
Joint effect of MCP-1 genotype GG and MMP-1 genotype 2G/2G increases the likelihood of developing pulmonary tuberculosis in BCG-vaccinated individuals. PLoS One (2010) 1.01
Origin of Mexican Nahuas (Aztecs) according to HLA genes and their relationships with worldwide populations. Mol Immunol (2006) 1.00
Time-zero renal biopsy in living kidney transplantation: a valuable opportunity to correlate predonation clinical data with histological abnormalities. Transplantation (2008) 1.00
Interleukin 1 receptor antagonist polymorphisms are associated with the risk of developing acute coronary syndrome in Mexicans. Immunol Lett (2010) 1.00
HLA-DR association with the genetic susceptibility to develop ashy dermatosis in Mexican Mestizo patients. J Am Acad Dermatol (2006) 0.98
Polymorphisms in the promoter region of tumor necrosis factor alpha (TNF-alpha) and the HLA-DRB1 locus in Mexican mestizo patients with ulcerative colitis. Immunol Lett (2004) 0.98
A report of the Lisbon Conference on the care of the kidney transplant recipient. Transplantation (2007) 0.97
HLA class I and class II conserved extended haplotypes and their fragments or blocks in Mexicans: implications for the study of genetic diversity in admixed populations. PLoS One (2013) 0.96
Systemic lupus erythematosus risk factors for coronary artery calcifications. Rheumatology (Oxford) (2011) 0.96
Clinical and genetic heterogeneity in Mexican patients with ulcerative colitis. Hum Immunol (2003) 0.95
Deficiency of red cell bound CD55 and CD59 in patients with systemic lupus erythematosus. Immunol Lett (2003) 0.94
ApoB-100, ApoE and CYP7A1 gene polymorphisms in Mexican patients with cholesterol gallstone disease. World J Gastroenterol (2010) 0.93
Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with rheumatic heart disease. J Autoimmun (2003) 0.92
HLA class I and class II haplotypes in admixed families from several regions of Mexico. Mol Immunol (2007) 0.90
MCP-1, RANTES, and SDF-1 polymorphisms in Mexican patients with systemic lupus erythematosus. Hum Immunol (2007) 0.90
Splenic marginal zone lymphoma with Evans' syndrome, autoimmunity, and peripheral gamma/delta T cells. Ann Hematol (2008) 0.90
Markers of inflammation before and after renal transplantation. Transplantation (2005) 0.90
P-glycoprotein in autoimmune diseases. Autoimmun Rev (2004) 0.90
Weekly dose of leflunomide for the treatment of refractory rheumatoid arthritis: an open pilot comparative study. Joint Bone Spine (2002) 0.90
Major histocompatibility complex and alveolar epithelial apoptosis in idiopathic pulmonary fibrosis. Hum Genet (2005) 0.89
Helicobacter pylori genotyping from American indigenous groups shows novel Amerindian vacA and cagA alleles and Asian, African and European admixture. PLoS One (2011) 0.89
Th17 peripheral cells are increased in diffuse cutaneous systemic sclerosis compared with limited illness: a cross-sectional study. Rheumatol Int (2011) 0.89
Genetic association of monocyte chemoattractant protein 1 (MCP-1)-2518 polymorphism in Mexican patients with transitional cell carcinoma of the bladder. Urology (2009) 0.88
Variants in toll-like receptor 9 gene influence susceptibility to tuberculosis in a Mexican population. J Transl Med (2013) 0.88
Immune response induced in vitro by CD16- and CD16+ monocyte-derived dendritic cells in patients with metastatic renal cell carcinoma treated with dendritic cell vaccines. J Clin Immunol (2004) 0.88
[The bacillus Calmette-Guérin as immunomodulator in bladder cancer]. Rev Invest Clin (2007) 0.88
PSMB8 (LMP7) but not PSMB9 (LMP2) gene polymorphisms are associated to pigeon breeder's hypersensitivity pneumonitis. Respir Med (2010) 0.88
Immunological aspects in chronic lymphocytic leukemia (CLL) development. Ann Hematol (2012) 0.88
Humoral immunity in tuberculin skin test anergy and its role in high-risk persons exposed to active tuberculosis. Mol Immunol (2009) 0.87
Inflammatory profile in cerebrospinal fluid of patients with headache as a manifestation of neuropsychiatric systemic lupus erythematosus. Rheumatology (Oxford) (2013) 0.87
MICA polymorphisms and decreased expression of the MICA receptor NKG2D contribute to idiopathic pulmonary fibrosis susceptibility. Hum Genet (2009) 0.86
Indoleamine 2,3-dioxygenase-expressing peripheral cells in rheumatoid arthritis and systemic lupus erythematosus: a cross-sectional study. Eur J Clin Invest (2011) 0.86
Class I and class II MHC polymorphisms in Mexican patients with Behçet's disease. Immunol Lett (2004) 0.85
Blood group O alleles in Native Americans: implications in the peopling of the Americas. Am J Phys Anthropol (2010) 0.85
IL-10-- and IL-20--expressing epithelial and inflammatory cells are increased in patients with ulcerative colitis. J Clin Immunol (2012) 0.84
Neurocognitive profile of an adult sample with chronic kidney disease. J Int Neuropsychol Soc (2010) 0.84
Association study of LMP gene polymorphisms in Mexican patients with spondyloarthritis. Hum Immunol (2004) 0.84
Inflammatory profile in the cerebrospinal fluid of patients with central neuropsychiatric lupus, with and without associated factors. Rheumatology (Oxford) (2009) 0.84
Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with spondyloarthritis. Hum Immunol (2006) 0.84
Reconstructing the history of Mesoamerican populations through the study of the mitochondrial DNA control region. PLoS One (2012) 0.84
Distribution of HLA-B alleles in Mexican Amerindian populations. Immunogenetics (2003) 0.84
CYP3A5 polymorphism in Mexican renal transplant recipients and its association with tacrolimus dosing. Arch Med Res (2012) 0.83
The role of indoleamine 2,3 dioxygenase in the induction of immune tolerance in organ transplantation. Transplant Rev (Orlando) (2010) 0.83
HLA-DR allele frequencies in Mexican mestizos with autoimmune liver diseases including overlap syndromes. Immunol Invest (2009) 0.83
Partial nephrectomy for renal tumors using selective parenchymal clamping. Int Urol Nephrol (2007) 0.83
Association of HLA-DR3 and HLA-DR4 with sinonasal polyposis in Mexican Mestizos. Otolaryngol Head Neck Surg (2006) 0.83
Tumor necrosis factor-alpha -308 promoter polymorphism contributes independently to HLA alleles in the severity of rheumatoid arthritis in Mexicans. J Autoimmun (2005) 0.83
Tumor necrosis factor-alpha promoter polymorphism in Mexican patients with Chagas' disease. Immunol Lett (2004) 0.83
Anti-major histocompatibility complex class I-related chain A antibodies in organ transplantation. Transplant Rev (Orlando) (2008) 0.82
P-glycoprotein activity in renal clear cell carcinoma. Urol Oncol (2008) 0.82
Mexican mestizo population sub-structure: effects on genetic and forensic statistical parameters. Mol Biol Rep (2012) 0.82
Systemic lupus erythematosus in Hispanics. Autoimmunity (2011) 0.82
Tumour Necrosis Factor alpha and Troponin T as predictors of poor prognosis in patients with stable heart failure. Clin Invest Med (2005) 0.82
TSPAN33 is a novel marker of activated and malignant B cells. Clin Immunol (2013) 0.82
HLA-DR6 association confers increased resistance to T. rubrum onychomycosis in Mexican Mestizos. Int J Dermatol (2010) 0.82
Comparative study of the residues 63 and 67 on the HLA-B molecule in patients with Takayasu's Arteritis. Immunol Lett (2005) 0.82
Assessment of emotional distress in chronic kidney disease patients and kidney transplant recipients. Rev Invest Clin (2013) 0.82
Intrahepatic bilioenteric anastomosis after biliary complications of liver transplantation: operative rescue of surgical failures. World J Surg (2009) 0.81
In vivo peripheral blood proinflammatory T cells in patients with ankylosing spondylitis. J Rheumatol (2012) 0.81
HLA genes in Mexican Teeneks: HLA genetic relationship with other worldwide populations. Mol Immunol (2005) 0.81
Persistence of decidual NK cells and KIR genotypes in healthy pregnant and preeclamptic women: a case-control study in the third trimester of gestation. Reprod Biol Endocrinol (2011) 0.81
MHC class II genes in Mexican patients with idiopathic dilated cardiomyopathy. Exp Mol Pathol (2006) 0.81
HLA-DR alleles associated with skin warts induced by human papillomavirus infection. Int J Dermatol (2010) 0.81
Angiotensin-converting enzyme gene (ACE) insertion/deletion polymorphism in Mexican populations. Hum Biol (2003) 0.80
Genetic variations in toll-like receptor 4 in Mexican-Mestizo patients with intra-abdominal infection and/or pneumonia. Immunol Lett (2013) 0.80
Does HLA-DR7 differentiate the overlap syndrome of auto-immune hepatitis-primary biliary cirrhosis (AIH-PBC) from those with auto-immune hepatitis type 1? Ann Hepatol (2011) 0.80
High resolution human leukocyte antigen (HLA) class I and class II allele typing in Mexican mestizo women with sporadic breast cancer: case-control study. BMC Cancer (2009) 0.80
Autoimmunity and lymphoma: is mantle cell lymphoma a mistake of the receptor editing mechanism? Leuk Res (2009) 0.79
Peripheral regulatory cells immunophenotyping in primary Sjögren's syndrome: a cross-sectional study. Arthritis Res Ther (2013) 0.79
Association of HLA-DR4 (DRB1*0404) with human papillomavirus infection in patients with focal epithelial hyperplasia. Arch Dermatol (2004) 0.79
Mineralocorticoid receptor blockade reduced oxidative stress in renal transplant recipients: a double-blind, randomized pilot study. Am J Nephrol (2013) 0.79
A pilot study on dual-energy computed tomography for detection of urate deposits in renal transplant patients with asymptomatic hyperuricemia. J Clin Rheumatol (2014) 0.79
Indoleamine 2,3-dioxygenase: expressing cells in inflammatory bowel disease-a cross-sectional study. Clin Dev Immunol (2013) 0.79